Ciprofloxacin in neonatal Enterobacter cloacae septicaemia.

Authors:
  • PSP R Stutchfield
    P R Stutchfield
  • AWA M Weindling
    A M Weindling
  • VDV Damjanovic
    V Damjanovic

Abstract
Multiresistant Enterobacter cloacae infection in six premature infants was eradicated with intravenous ciprofloxacin (10 mg/kg/day). Bacterial resistance did not develop. Adequate plasma ciprofloxacin concentrations were achieved in all treated patients. No clinical evidence of side effects was observed.